Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug approvals
Fierce Pharma
FDA approves leucovorin without clinical trial—but not for autism
The FDA has used real-world data to approve leucovorin to treat cerebral folate deficiency in patients who have a confirmed variant in the FOLR1 gene.
Angus Liu
,
Darren Incorvaia
Mar 10, 2026 9:00am
FDA plans real-time release of drug rejection letters
Sep 4, 2025 1:45pm
Fierce Pharma
FDA's response letter salvo sheds light on drug refusal process
Jul 11, 2025 10:15am
FDA shares more than 200 CRLs for now-approved drugs
Jul 10, 2025 10:54am
FDA single-trial guidance calls for the good, bad and ugly data
Sep 19, 2023 10:15am
The FDA's decision on aducanumab will drag down science
Jun 9, 2021 8:45am